November 18, 2019
The US FDA has approved Shionogi’s novel antibiotic cefiderocol, which now carries the brand name of Fetroja, for the treatment of complicated urinary tract infections (cUTI) in patients aged 18 and older who have limited or no alternative options. The...read more